Status:
COMPLETED
Medication Adherence Patterns in Rheumatic Diseases: A Behavioral Trial
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Rheumatic Diseases
Gout
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Non-adherence to evidence-based prescription medications results in preventable morbidity and mortality for middle-aged and older adults. Taking medications intended for daily use, like those to preve...
Detailed Description
Non-adherence to evidence-based prescription medications results in preventable morbidity and mortality for middle-aged and older adults. Taking medications intended for daily use, like those to preve...
Eligibility Criteria
Inclusion
- English-speaking patients
- receiving their care at a Brigham and Women's Hospital-affiliated rheumatology practice
- \>=18 years of age
- with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), or gout
- prescribed \>=1 oral medication for this disease for \>=4 months.
- for patients with gout, had a uric acid level checked in the prior 18 months and the most recent level is \>6.
- for patients with SLE, their most recent c-reactive protein level collected in the past 18 months must be \>10.
- currently have a smartphone with a data plan or WiFi at home
- willing and able to set up the platform and adhere to study procedures
- either not currently using a pillbox or willing to use electronic pill bottles (EDMs) for diabetes medications for the duration of the study
Exclusion
- Pregnant women
- Incarcerated individuals
Key Trial Info
Start Date :
August 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2022
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04776161
Start Date
August 2 2021
End Date
November 10 2022
Last Update
October 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115